Article Details
Retrieved on: 2022-03-30 03:49:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Federal Court dismissing Alexion's application for judicial review, ... that Alexion's SOLIRIS (eculizumab) was sold at an excessive price.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here